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A novel pathway for MuSK to induce key genes 
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t the developing neuromuscular junction the Agrin
receptor MuSK is the central organizer of subsynaptic
differentiation induced by Agrin from the nerve. The
expression of 
 
musk
 
 itself is also regulated by the nerve, but
the mechanisms involved are not known. Here, we analyzed
the activation of a 
 
musk
 
 promoter reporter construct in
muscle ﬁbers in vivo and in cultured myotubes, using
transfection of multiple combinations of expression vectors
for potential signaling components. We show that neuronal
Agrin by activating MuSK regulates the expression of 
 
musk
 
via two pathways: the Agrin-induced assembly of muscle-
derived neuregulin (NRG)-1/ErbB, the pathway thought to
A
 
regulate acetylcholine receptor (AChR) expression at the
 
synapse, and via a direct shunt involving Agrin-induced
activation of Rac. Both pathways converge onto the same
regulatory element in the 
 
musk
 
 promoter that is also
thought to confer synapse-speciﬁc expression to 
 
AChR
 
 sub-
unit genes. In this way, a positive feedback signaling loop is
established that maintains 
 
musk
 
 expression at the synapse
when impulse transmission becomes functional. The same
pathways are used to regulate synaptic expression of
 
AChR
 
 
 
 .
 
 We propose that the novel pathway stabilizes the
synapse early in development, whereas the NRG/ErbB
pathway supports maintenance of the mature synapse.
 
Introduction
 
The formation of a subsynaptic apparatus at the neuromuscular
junction is an example of extreme subcellular differentiation
induced by the motor neuron in a small segment of the muscle
fiber. Four key components have been identified in this process:
Agrin, a heparansulfate proteoglycan secreted from the motor
nerve; MuSK, a component of the Agrin receptor complex;
acetylcholine receptors (AChRs);* and rapsyn, a peripheral
membrane component required for the aggregation of the
AChRs in the muscle membrane. Agrin/MuSK act upstream
of AChRs and rapsyn, but deletion of any of these compo-
nents prevents synapse formation (Schaeffer et al., 2001).
When a synapse forms, a group of muscle nuclei driven by
signals from the nerve selectively begins to transcribe genes
coding for proteins involved in synapse formation and main-
tenance, including 
 
AChR
 
 subunit genes. Two major factors
expressed in motor nerves, neuregulin (NRG)-1 and Agrin,
have been invoked in this process. NRG-1, by activating
ErbB receptor tyrosine kinases in the muscle membrane, is
thought to activate 
 
AChR
 
 genes (Burden and Yarden, 1997;
Fischbach and Rosen, 1997). Agrin by activating the receptor
tyrosine kinase MuSK aggregates the AChRs and MuSK in
the membrane. In cultured myotubes, activation of ErbB
 
receptors by NRG-1 activates 
 
AChR
 
 
 
, 
 
 
 
, and 
 
 
 
 subunit gene
transcription via the MAPK (extracellular signal–regulated
kinase [ERK]) and the phosphatidylinositol 3
 
 
 
-kinase pathways
(Tansey et al., 1996; Altiok et al., 1997). ERK in turn activates
the Ets transcription factor GABP to bind to a regulatory
element in the 
 
AChR
 
 
 
 and 
 
 
 
 promoters, termed N-box, thus
stimulating the transcription of the respective genes. The
same regulatory element also mediates the localization of
 
AChR
 
  
 
and 
 
 
 
 subunit expression to the synapse (Koike et
al., 1995; Duclert et al., 1996; Fromm and Burden, 1998;
Schaeffer et al., 1998; Sapru, 2001). Together these data
suggest that the nerve regulates synaptic 
 
AChR
 
 expression via
NRG-1. However, NRG-1 from neurones is not required to
induce 
 
AChR
 
 genes in muscle fibers. Specifically, activation
of MuSK by Agrin induces the formation of a postsynaptic
membrane including 
 
AChR
 
 expression in vivo in the absence
of a nerve terminal and thus of neural NRG-1 (Cohen et al.,
1997; Jones et al., 1997; Meier et al., 1997).
The mRNA for MuSK also accumulates at the synapse,
suggesting synapse-specific activation of its gene by the nerve
(Valenzuela et al., 1995), but the mechanisms involved are
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not known. The spatio-temporal expression pattern of 
 
musk
 
is similar to that of the 
 
AChRs
 
. In fetal muscles, 
 
musk
 
mRNA is expressed constitutively along the entire length of
the fibers. In adult fibers, a neural signal locally induces
 
musk
 
 mRNA (Valenzuela et al., 1995; Bowen et al., 1998),
perhaps through Agrin/MuSK (Moore et al., 2001). On the
other hand, in cultured myotubes 
 
musk
 
 mRNA is also up-
regulated by NRG-1 (Ip et al., 2000).
Here, we describe experiments aimed at elucidating the
mechanism involved in the nerve-induced expression of
MuSK at the synapse and the roles of Agrin and NRG-1 in
this process. The results indicate that synaptic expression of
 
musk
 
 depends on the presence of an N-box in the 
 
musk
 
 pro-
moter. Similarly, 
 
musk
 
 is activated through this N-box by
neuronal Agrin via the activation of MuSK. Agrin-induced
 
musk
 
 expression is controlled in part by a secondary NRG/
ErbB pathway organized by Agrin/MuSK and in part by a
novel shunt path in which MuSK signals to the muscle nuclei
more directly via Rac and c-Jun NH
 
2
 
-terminal kinase (JNK)
but is independent of NRG/ErbB. Remarkably, 
 
AChR
 
 
 
 sub-
unit expression is regulated via the same pathways. Thus, the
nerve uses identical pathways to regulate the expression of
key components in neuromuscular synapse formation.
 
Results
 
Cloning of the 
 
nsk2/musk
 
 promoter sequence
 
We screened a mouse genomic phage library with a 500-bp 5
 
 
 
cDNA fragment of 
 
nsk2
 
, the mouse ortholog of rat and human
 
musk
 
, and isolated 10 kb of mouse genomic sequence contain-
ing 5 kb each upstream and downstream of the first exon of
 
nsk2
 
 (Ganju et al., 1995). We denote this a 
 
nsk2/musk
 
 frag-
ment. The transcription start site (
 
 
 
1) in 
 
nsk2/musk
 
 was deter-
mined by 5
 
 
 
 RACE (Fig. 1 A). The upstream region is TATA-
less and lacks an obvious initiator element but contains several
potential binding sites for transcription factors. Specifically,
eight E-boxes are contained within the 1.6 kb upstream from
the transcription start site (Fig. 1 B). The two proximal E-boxes
(
 
 
 
40/
 
 
 
45 and –147/–152) are conserved between mouse 
 
nsk2
 
and the human 
 
musk
 
 ortholog (Fig. 1 A). E-boxes are thought
to mediate muscle-specific and activity-dependent expression of
 
AChR
 
 genes (Tang et al., 1994; Angus et al., 2001) by binding
basic helix–loop–helix transcription factors of the myoD family
(Schaeffer et al., 2001). Another putative E-box was found in
the first intron at position 
 
 
 
920 (Fig. 1, A and B). Importantly,
the first intron of the 
 
nsk2
 
 gene also contains at 
 
 
 
871 an
N-box, 5
 
 
 
-GTACCGGAAATA-3
 
 
 
 (Fig. 1, A and B). Its se-
quence is identical to the N-box of the AChR
 
  
 
subunit gene
promoter where it is thought to mediate nerve- and NRG-
induced transcription of the 
 
AChR
 
 
 
 subunit gene (Duclert et
al., 1993, 1996; Schaeffer et al., 1998). When compared with
the human sequence, the overall identity of the first intron in
mouse and human 
 
nsk2/musk
 
 is 74%, with the N-box located
in a very highly conserved (91%) stretch of 80 bp which also
contains putative-binding sites for TEF-1 and AP-1 (Fig. 1 A).
 
A 2.1-kb 
 
nsk2/musk
 
 promoter fragment mediates 
synapse-specific expression
 
Next, we examined whether a 2.1-kb 
 
nsk2/musk
 
 fragment
contained regulatory elements conferring the physiological
expression pattern to 
 
nsk2/musk
 
, i.e., synapse-specific expres-
sion in electrically active fibers and an increase in expression
in nonsynaptic regions upon muscle denervation (Valenzu-
ela et al., 1995).
Figure 1. Regulatory sequences of the nsk2 gene. (A) Sequence 
comparison of the mouse (top) and the human (bottom) promoter 
regions with exon1 and part of the first intron of the nsk2/musk gene. 
The putative transcription start determined by 5  RACE PCR is indicated 
as  1 for the mouse sequence. Boxes indicate E-boxes, the oval 
shows the N-box, black arrows show Sp1/Egr-1 putative binding 
sites, the large dotted line indicates a putative NF- B binding site, 
the small dotted line indicates a putative TEF-1 binding site, and a 
putative AP-1 binding site is underlined. (B) Schematic representation 
of a larger region upstream and downstream the first exon. Potential 
binding sites for transcription factors are indicated. Prediction of 
the transcription factor binding site have been generated with the 
MatInspector software from Genomatix. (C) Schematic diagram of 
the different constructs used in vitro or in vivo experiments with 
either the luciferase gene or the lacZ gene as a reporter.T
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To test for synapse-specific activation, the proximal 1.6-
kb upstream region was linked to nls
 
lacZ
 
 as a reporter, fol-
lowed by 0.5 kb of intronic sequence containing the N-box
(Fig. 1 C, p1.6nlslacZ-N). Innervated, i.e., electrically active
rat soleus muscles were then transfected in vivo by electropo-
ration with p1.6nlslacZ-N, and synapse-specific expression
of nls
 
lacZ
 
 was tested 10–14 d later in the microscope by ex-
amining the location of muscle nuclei expressing 
 
 
 
-galac-
tosidase (
 
 
 
-Gal)–positive nuclei with respect to the location
of synapses. The latter were marked by histochemical stain-
ing for acetylcholinesterase (AChE). Indeed, in some fibers
 
 
 
-Gal–positive nuclei were tightly colocalized with synapses
(Fig. 2 A); in other fibers they were also seen in nonsynaptic
regions. To see whether the AChE/
 
 
 
-Gal colocalization re-
flected preferential activation of the 
 
nsk2/musk
 
 promoter
fragment at the synapse, we compared the number of 
 
 
 
-Gal/
AChE colocalizations expected for a random process with
the number of colocalizations actually observed. For this
purpose, fiber bundles were dissected, and the lengths of fi-
ber segments occupied by 
 
 
 
-Gal–positive nuclei relative to
the length of the dissected fibers were determined. This ratio
multiplied by the number of 
 
 
 
-Gal–positive fibers examined
gives the number of 
 
 
 
-Gal–positive synapses expected for
random colocalization. Comparison with the number of
 
 
 
-Gal/AChE colocalizations actually observed showed that
 
 
 
-Gal–positive synapses occurred five to six times more fre-
quently than expected by chance (Fig. 2 B).
To test the 
 
nsk2/musk
 
 promoter fragment for its activation
by muscle denervation, nls
 
lacZ
 
 in p1.6nlslacZ-N was replaced
by the cDNA encoding firefly luciferase (luc) as a reporter
(Fig. 1 C, p1.6luc-N). Innervated, i.e., electrically active rat
soleus muscles were then electroporated in vivo with a mixture
of p1.6luc-N and an expression vector for Renilla luciferase,
pRL-TK, as a reference. 10–13 d later, the soleus nerve was
cut. After another 4 d, luciferase activities normalized to RL-
TK activity in muscle extracts were compared with those in
transfected control fibers that had been left innervated. The
comparison revealed a significant twofold increase in normal-
ized luciferase activities upon denervation (Fig. 2 D). A simi-
lar increase was seen when the N-box was mutated as de-
scribed in the next paragraph, indicating that up-regulation by
denervation was not dependent on the N-box. Finally, the ex-
pression profile of p1.6luc-N during in vitro differentiation of
C2C12 muscle cells was similar to that of endogenous 
 
musk
 
mRNA in these cells, i.e., a low level in myoblasts followed by
a strong increase in differentiating myotubes (Valenzuela et
al., 1995), and it was not affected by mutations in the N-box
(Fig. 2, E and F). Thus, the isolated 2.1-kb promoter frag-
ment of 
 
nsk2/musk
 
 confers expression patterns to the reporters
as they are observed for endogenous 
 
musk
 
.
 
Agrin activates the 2.1-kb 
 
nsk2/musk
 
 fragment 
conferring synapse-specific expression in vivo 
via an N-box
 
Expression of endogenous 
 
musk
 
 can be induced by Agrin/
MuSK (Moore et al., 2001). Therefore, we next tested
whether the 2.1-kb 
 
nsk2/musk
 
 promoter fragment confer-
ring synaptic expression could be activated specifically by
neuronal Agrin. For this purpose, we injected expression
plasmids coding for full-length chicken neuronal Agrin,
pcAgrin748, p1.6luc-N, and pRL-TK as a reference along
with pnlsGFP-S6 intracellularly into extrasynaptic regions of
innervated soleus muscles. As a control, pcAgrin748 was re-
placed with an expression vector for the nonneuronal iso-
form of Agrin, pcAgrin700 (Ruegg et al., 1992). 2 wk later,
in fiber regions containing GFP-positive nuclei, luciferase
activity measured in fibers expressing neuronal Agrin was
 
 
 
3.5 times higher than in fibers expressing muscle Agrin
(Fig. 3 A). On a “per nucleus” basis, this is a lower estimate
because the fiber segments dissected (2–3 mm in length)
Figure 2. A 2.1-kb nsk2/musk promoter fragment confers spatio-
temporal expression patterns to reporters comparable to those 
of endogenous musk. (A) Examples of endplates marked by 
histochemical staining for AChE and expressing colocalized 
 -Gal–positive nuclei upon transfection with p(1.6nlslacZ-N). 
Nuclei are in blue and AChE is in brown. Bar, 40  m. (B) The 
percentage of  -Gal–positive fibers with colocalizations of  -Gal–
positive nuclei and synaptic AChE observed (as illustrated in A) 
is significantly higher than expected for a random process. Means   
SE are given (n   4 muscles, 17–56  -Gal–positive fibers [170 fibers 
total] examined per muscle). (C) The level of firefly luciferase (luc) 
activity expressed upon transfection with p(1.6luc-N) increases 
linearly with the activity of a cotransfected standard, p(RL-TK), of 
Renilla luciferase, indicating that normalization to RL-TK expression 
to account for differences in transfection efficiency between 
muscles as performed in D is appropriate. (D) The 2.1-kb nsk2/
musk promoter fragment responds to muscle denervation (4 d) by 
increasing expression of luciferase activity (means   SE, n   5). 
In the same experiments, the levels of RL-TK were not significantly 
different in innervated control and in denervated fibers (data not 
depicted). (E) Activation of p1.6luc-N and p1.6luc-Nmut in C2C12 
myoblasts and in differentiating myotubes (n   3 parallel cultures 
for each transfected plasmid). *P   0.05 and **P   0.01 in two-
tailed t test. Bars   SEM.T
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contained many more GFP-positive nuclei outside the
Agrin-induced ectopic, postsynaptic membranes (and thus
not activated by Agrin) than nuclei colocalized with such
sites. Thus, neuronal Agrin but not muscle Agrin activates
the same 2.1-kb nsk2/musk promoter fragment, (1.6 N) as
does the nerve.
Unlike during myotube differentiation and upon denerva-
tion, the N-box of musk was essential for the activation of
the musk promoter by Agrin. When two nucleotides in the
N-box were mutated (CCGGAA → TTGGAA) to produce
p1.6luc-Nmut, agrin-induced luciferase activity was signifi-
cantly reduced (Fig. 3 A).
Neuronal Agrin triggers N-box–dependent musk 
expression in C2C12 myotubes
For further characterization of the nsk2/musk promoter, the
responsiveness to Agrin of different promoter fragments of
various lengths was examined by transactivation assays in
C2C12 myotubes. In these experiments, a minimal variant
of recombinant neuronal Agrin, cAgrinNtAc21B8 (Meier et
al., 1998a), was presented to the myotubes in a form at-
tached to the laminin culture substrate. Indeed, p1.6luc-N
showing physiological activation in vivo also responded to
neuronal mini-Agrin in myotubes but only when the N-box
was intact (Fig. 3 B). Similar results were obtained when,
immediately upstream from the transcription start site, the
promoter was reduced to 0.2 kb (p0.2luc-N; unpublished
data) or when it was extended to contain 5.4 kb of upstream
sequence (p5.4luc-N; Fig. 1 C), except that basal luciferase
activities and the response to Agrin increased somewhat as
the upstream fragment length was increased (unpublished
data). However, in all cases constructs required the presence
of the intronic N-box to respond to Agrin (Fig. 3 C).
Binding of inactive GABP to the N-box blocks 
activation of nsk2/musk by Agrin
In cultured myotubes, musk, like AChR, is also activated by
NRG-1 (Ip et al., 2000). The NRG-dependent activation of
AChR genes depends on the binding of active transcription
factor GABP to the N-box (Koike et al., 1995; Duclert
et al., 1996; Fromm and Burden, 1998; Schaeffer et al.,
1998). Therefore, we next tested in mobility shift assays
whether the transcription factor complex GABP, composed
of GABP - and   subunits (Batchelor et al., 1998), binds to
the N-box of the nsk2/musk promoter fragment, using a ra-
diolabeled 24-base fragment of the first intron containing
the N-box motif as a probe. Exposure of the probe to nu-
clear extracts from C2C12 myotubes revealed binding activ-
ity in the extract (Fig. 4 A). Adding nonlabeled probe elimi-
nated the detectable shifted complex, indicating specificity
of binding. Integrity of the N-box was necessary, since the
nonradiolabeled probe with the N-box mutated was ineffec-
tive in competing for binding of the nuclear extract (Fig. 4,
A and C). We next examined whether addition of a 24-
nucleotide fragment of the rat AChR  subunit promoter,
which also contains an N-box,  -comp (Fig. 4 B), could
compete for binding activity from C2C12 nuclear extracts.
Indeed, a 25-fold molar excess of  -comp prevented the re-
tardation of the labeled N-box probe from nsk2/musk that
had been produced by the addition of C2C12 nuclear ex-
tract (Fig. 4 C). Furthermore, a supershift was produced by
binding of anti-GABP  or anti-GABP  antibodies (Fig. 4
D). Likewise, when the labeled probe was exposed to an ex-
tract from HEK293 cells transiently expressing myc-tagged
GABP  and GABP , respectively, supershifts were observed
in the presence of anti-myc antibody (Fig. 4 E). These data
combined indicate that the N-box motif of the MuSK pro-
moter specifically binds GABP.
Next, we tested whether Agrin-induced musk activation
was abolished by binding of an inactive mutant of GABP.
For this purpose, we compared in C2C12 myotubes the re-
sponse of p1.6luc-N to Agrin in the presence and in the ab-
sence of pGABP DN, an inactive mutant of GABP ,
Figure 3. Neuronal but not muscle agrin activates nsk2/musk 
promoter fragments, depending on an N-box in the first intron. 
(A) Expression of luciferase activity under the control of the (1.6-N) 
promoter fragment in adult soleus muscle fibers in vivo is promoted 
by neuronal but not my muscle Agrin and is blocked upon mutation 
of the N-box. Muscle fibers were injected intracellularly with the 
expression plasmids indicated and with pRL-TK for normalization. 
(B) Agrin-induced expression of luciferase under the control of 
various nsk2/musk promoter fragments depends on the presence of 
the N-box in C2C12 myotubes. C2C12 myoblasts were transfected 
with pRL-TK and the plasmids indicated and grown and differentiated 
on a laminin substrate with or without mini-Agrin N257c21B8 
attached. (C) Agrin-induced activation of a 5.4-kb nsk2/musk 
promoter fragment in C2C12 myotubes is blocked by removal of the 
intronic sequence containing the N-box. ***P   0.001 in two-tailed 
t test. Bars   SEM.T
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which blocks activation of AChR genes in cultured myotubes
(Schaeffer et al., 1998) and Agrin-induced postsynaptic dif-
ferentiation in vivo (Briguet and Rüegg, 2000). Indeed,
overexpression of GABP DN abolished the induction of lu-
ciferase activity under the 1.6-N promoter fragment by
mini-Agrin (Fig. 4 F). In fact, luciferase activity in Agrin-
exposed, GABP DN-overexpressing cultures were below
those in Agrin-free control cultures, suggesting some consti-
tutive activity of GABP or a similar factor in the absence of
Agrin. Thus, induction of musk expression by neuronal
Agrin involves binding of GABP or a related factor to the in-
tronic N-box.
Agrin can activate the nsk2/musk promoter via two 
pathways converging on the N-box
In cultured myotubes, NRG-1/ErbB-induced activation of
AChR  and   is mediated by ERK and JNK MAPKs (Tan-
sey et al., 1996; Altiok et al., 1997; Si et al., 1999). There-
fore, we examined whether nsk2/musk was induced indirectly
by Agrin, i.e., via the organization of an NRG-1/ErbB path-
way with NRG derived from the myotubes, as we had
observed previously for the induction of AChR  by Ag-
rin (Meier et al., 1998b). As predicted for such a mecha-
nism, activation of p1.6luc-N by mini-Agrin in C2C12 myo-
tubes was abolished by overexpression of pHER2KM or
pHER4KM, dominant-negative mutants of ErbB2 and
ErbB4 (Fig. 5 A). Activation of nsk2/musk by Agrin was also
blocked by overexpression of a dominant-negative mutant of
JNK, pJNK-APF (Fig. 5 B). Conversely, a constitutively
active mutant of MKK7, pMKK7D, which activates JNK,
induced nsk2/musk in the absence of Agrin. A promoter–
reporter construct of AChR  (Jones et al., 1996) was regu-
lated similarly (Fig. 5 C). These data suggest that Agrin or-
ganizes a secondary NRG-1/ErbB pathway, which in turn
activates musk and AChR  via ERK and JNK.
Next, we asked whether Agrin could also activate musk via
a direct shunt from MuSK. For example, an alternative way
for Agrin to activate JNK in C2C12 cells is via the Rho fam-
ily GTPases Rac and Cdc42 (Weston et al., 2000; Luo et al.,
2002). Consistent with such a mechanism, constitutively ac-
tive Rac, RacV12, strongly activated p(1.6luc-N) in the ab-
sence of Agrin. This effect was abolished by GABP DN
(Fig. 5 D), suggesting that Rac activates nsk2/musk via the
N-box only. If Agrin-induced activation of musk via Rac occurs
independently of NRG/ErbB, Agrin will induce p1.6luc-N
more strongly than saturating concentrations of NRG-1, and
induction will be blocked by a dominant-negative mutant of
Rac, RacN17. In normal C2C12 myotubes, no difference in
the activation of p1.6luc-N by Agrin and by NRG-1 was re-
solved (unpublished data). However, when ErbB signaling
was blocked by overexpression of inactive ErbB mutants,
Agrin activated p(1.6luc-N) more strongly than saturating
concentrations of NRG-1 (2 nM), which was not due to in-
creased levels of ErbB2 (Fig. 5 F). Furthermore, activation
was completely blocked by RacN17 (Fig. 5 E). Together,
these data suggest that Agrin/MuSK can activate nsk2/musk
via two pathways (Fig. 7): (a) via a direct shunt activated by
MuSK involving Rac and (b) via the organization of a sec-
ondary NRG-1/ErbB pathway. Both pathways converge
onto GABP. In C2C12 myotubes, the secondary NRG-1/
ErbB pathway occludes the MuSK-induced shunt.
Next, we examined whether these pathways could be re-
solved in muscle fibers in vivo. Unlike in C2C12 cells, acti-
vation of nsk2/musk by Agrin was not blocked in adult fibers
Figure 4. GABP binds to the N-box of a nsk2/musk 
promoter fragment and activates it. (A) Binding 
activity of wild-type nuclear extracts to the N-box 
present in the probe. The specificity of the signal 
is eliminated by competition with an unlabeled 
wild-type probe (WTcomp), whereas an unlabeled 
mutant competitor (MUTcomp) leaves the signal 
unaffected. (B) Sequences of the oligonucleotides 
used as probes or competitors. (C) Unlabeled 
oligonucleotide containing the N-box motif of the 
AChR  subunit promoter ( -comp) competes with 
N-box of musk for binding of nuclear extract. 
(D) The N-box binding activity produced by nuclear 
extracts from C2C12 cells (lane 1) is supershifted 
(bold arrow) by antibodies directed against GABP  
(lane 2) and GABP  (lane 3). (E) Nuclear extracts of 
transiently transfected HEK293 cells expressing 
GABP -myc and GABP -myc (lanes 1 and 2) or 
only GABP -myc (lanes 3 and 4) or GABP -myc 
(lanes 5 and 6) possess an N-box binding activity 
(arrow), which is supershifted (bold arrow) in the 
presence of an anti-myc antibody (Ab, lanes 2, 4, 
and 6). The second band seen in the shift may 
originate from binding activity specific for HEK293 
cells. (F) Agrin-induced activation of the 2.1-kb 
nsk2/musk promoter fragment in C2C12 myotubes 
is blocked by overexpression of GABP DN. 
***P   0.001 in two-tailed t test. Bars   SEM. 
Note that for better resolution of the agrin-specific 
induction, luciferase activities in parallel control 
cultures (not depicted) are subtracted.T
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by overexpression of the inactive ErbB mutants. Specifically,
upon injection with pHER2KM and pHER4KM into mus-
cle fibers in vivo, activation of p1.6luc-N by neuronal Agrin
was not significantly reduced compared with fibers injected
with wild-type pHER2 and pHER4 (Fig. 6 A). Expression
of pHERKM and accumulation of HER2KM at ectopic
sites was ascertained by immunocytochemistry (Fig. 6 B).
Similar results were obtained with the AChR  promoter–
reporter construct (unpublished data).
In contrast, overexpression of the inactive JNK mutant,
JNK-APF, did block musk activation by Agrin (Fig. 6 A).
Furthermore, with JNK-APF overexpressed the presence of
HER2KM and HER4KM did not inhibit the promoter acti-
vation any further. Conversely, coinjection of pMKK7D sig-
nificantly increased musk activation by Agrin in muscle fi-
bers. Therefore, in adult fibers Agrin/MuSK induces nsk2/
musk primarily via a direct shunt involving Rac and JNK ac-
tivation but not NRG/ErbB signaling.
If active JNK activation promotes gene expression at the
synapse, then inactive JNK-APF is predicted to inhibit
Agrin-induced expression of endogenous synaptic genes,
such as musk and AChR . We tested this prediction in vivo
Figure 5. Agrin uses two pathways for the 
activation of the 2.1-kb nsk2/musk promoter 
fragment in cultured myotubes. (A) In C2C12 
myotubes, activation of p1.6luc-N by Agrin is fully 
blocked by HER2KM and HER4KM, dominant-
negative mutants of human ErbB2 and ErbB4, 
respectively, whereas wild-type HER2 mimics the 
induction by Agrin. (B) Same as in A but blockade 
by dominant-negative JNK, JNK-APF; conversely, 
overexpression of MKK7D, a constitutively active 
kinase activating JNK, activates the fragment in the 
absence of Agrin. (C) Same as in B but with an 
AChR  promoter fragment (pLCF216 ). Note 
similar activation patterns of nsk2/musk and AChR  
promoter fragments. (D) Constitutively active Rac, 
RacV12, activates p1.6luc-N; induction by Rac is 
completely blocked by GABP DN. (E) With ErbB 
signaling blocked, p1.6luc-N is activated more 
strongly by agrin than by saturating (2 nM) NRG-1, 
and responses are fully blocked by dominant-
negative Rac, RacN17. Constitutively active Rac, 
RacV12, strongly activates the promoter in spite of 
blockade of ErbB signaling. All experiments were 
performed on C2C12 cells transfected with 
p1.6luc-N. (F) Agrin does not discernibly increase 
ErbB2 levels in C2C12 myotubes. Experiments 
performed as in Fig. 3 with plasmids transfected as indicated. Responses are normalized to control values in the left-hand columns, and 
nonspecific background luciferase activities as observed in myotubes on agrin-free substrate are subtracted (C). *P   0.05, **P   0.01, and 
***P   0.001, respectively, in two-tailed t test. Bars   SEM.
Figure 6. Agrin activates nsk2/musk via an ErbB-
independent pathway in muscle fibers in vivo. 
(A) Activation of the nsk2/musk promoter fragment by 
Agrin in vivo is marginally affected by HER2KM and 
HER4KM but is fully blocked by JNK-APF. MKK7D 
activates the nsk2/musk fragment in the absence of 
Agrin. Nonspecific background luciferase activities 
as observed in muscle fibers injected with expression 
vector for muscle agrin (pcAgrin700; see Fig. 3 A) 
are subtracted. (B) Injection of pHERKM induces 
expression of HERKM in muscle fibers in vivo as myc 
immunoreactivity was observed at agrin-induced 
ectopic postsynaptic membranes upon injecting 
pmyc_HER2KM, a fusion of HER2KM and myc. Bar, 
25  m. (C) JNK-APF inhibits ectopic subsynaptic 
differentiation by Agrin. Muscle fibers were injected 
with pcAgrin748, pnslGFP, and pJNK-APF or equivalent 
amounts of empty vector (control); the formation of 
ectopic AChR clusters in GFP-positive fibers was then 
examined in cross sections, and injected fibers were 
identified by their expression of GFP. (Top) Control fiber (note the formation of AChR cluster [red] in GFP-positive control fiber [green nuclei]). 
(Middle) Agrin secreted induces AChR cluster on adjacent, GFP-negative (JNK-APF–negative) but not on GFP- (JNK-APF) expressing fiber. Bar, 
25  m. (Bottom) The percentage of GFP-positive fibers forming AChR clusters in response to Agrin is depressed in JNK-APF compared with 
control fibers. Each data point represents one muscle. 83–513 fiber profiles were examined per muscle.T
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by analyzing whether JNK-APF blocked Agrin-induced
ectopic subsynaptic differentiation. Indeed, injection of
pJNK-APF significantly reduced the formation of ectopic
AChR clusters in electrically active fibers (Fig. 6 C). Since
overexpression of inactive JNK does not affect AChR clus-
tering itself (Luo et al., 2002), the inhibition is due to down-
regulation of expression of genes important in synapse for-
mation, such as musk and AChR.
Discussion
To understand how the motor neuron regulates the formation
of a subsynaptic muscle membrane, it is important to know
how it regulates expression of MuSK, the central organizer of
subsynaptic differentiation. Endogenous musk is stimulated in
vivo by activated MuSK (Moore et al., 2001), but the path-
ways involved are not known. Here, we have used various
nsk2/musk promoter–reporter constructs comprising up to 5.4
kb upstream and 0.5-kb sequence from the first intron to ana-
lyze the signaling pathways activated by the nerve and by
Agrin in muscle fibers in vivo and in cultured myotubes.
Using these constructs, we show the following: (a) the
nerve can induce activation of nsk2/musk promoter frag-
ments via pathways converging on a regulatory sequence
termed N-box in the first intron of musk; (b) Agrin activates
the nsk2/musk promoter fragments solely via the binding of
an Ets transcription factor to this N-box; (c) activation is
mediated by two converging pathways, the organization of
an NRG-1/ErbB pathway and a novel NRG-1/ErbB-inde-
pendent pathway via MuSK/Rac; (d) the NRG-1/ErbB-
mediated pathway predominates in cultured myotubes, the
other in muscle fibers in vivo; and (e) these pathways are also
used for the regulation of an AChR  promoter fragment.
Recently, it has been proposed that NRG may regulate
AChR  and AChR  subunit genes via Sp1 binding to a neu-
regulin response element (CCACCCCC) different from the
N-box in their promoters (Alroy et al., 1999). The p5.4luc-N
construct contains at approximately –3.4 kb a consensus se-
quence of this type. However, neither this putative neu-
regulin response element nor an Sp1-binding consensus se-
quence at position –112 in the musk promoter rescued the
construct’s responsiveness to Agrin when it was lacking the
N-box, indicating that these sequences are not involved in
the regulation of musk by Agrin.
An important aspect of the physiological relevance of the
exogenous promoter fragment is whether it reflects the expres-
sion pattern of endogenous musk in vivo. The 2.1-kb nsk2/
musk fragment used for most experiments here satisfies this
criterion, except that the specificity of the reporter expression
at the synapse and its relative increase upon denervation were
less pronounced. This was likely due to nonspecific activation
of the transfected promoter fragment in extrasynaptic fiber
segments, perhaps caused by a high number of plasmid mole-
cules introduced into the fibers or by the absence of regulatory
elements that are located beyond this region.
In cultured myotubes, the organization of a secondary
NRG-1/ErbB pathway by Agrin is suggested by the block-
ade of Agrin-induced nsk2/musk promoter activation upon
inhibition of ErbB-mediated signaling as found previously
for AChR  (Meier et al., 1998b). Induction of AChR  via
NRG is mediated by ERK (Tansey et al., 1996; Altiok et al.,
1997) and involves activation of JNK MAPKs (Si et al.,
1999). Specifically, although inactive JNK blocks NRG-
induced AChR  activation, overexpression of wild-type JNK
has no effect, suggesting that JNK is necessary but not suffi-
cient to induce AChR , but requires ERK (Si et al., 1999).
However, the present data suggest that JNK can activate
musk independently of NRG/ErbB. (a) In spite of ErbB sig-
naling blocked, musk was activated by constitutively active
RacV12 (Fig. 5 E). Interestingly, JNK is activated by Agrin/
MuSK in C2C12 myotubes via Rac (Weston et al., 2000)
and via Dishevelled (Luo et al., 2002). (b) With ErbB sig-
naling blocked, musk activation by Agrin was stronger than
by saturating concentrations of NRG, and activation was
completely blocked by dominant-negative RacN17. There-
fore, these findings suggest that in addition to the NRG/
ErbB pathway Agrin activates an ErbB-independent shunt
via Rac/JNK to induce musk. Both converge on GABP be-
cause GABP binds to the N-box, and its inactive mutant
GABP DN completely blocks ErbB- and Rac-dependent
activation of musk. One explanation for the prevalence of
the ErbB-dependent pathway in C2C12 cells may be the
high levels of constitutively expressed NRG-1 and ErbBs in
these cells (Meier et al., 1998b) which could favor the orga-
nization of the NRG/ErbB pathway.
In contrast, in muscle fibers in vivo, musk induction by
Agrin is only marginally mediated by NRG/ErbB because it
is little affected by HER2KM and HER4KM. Thus, Agrin
appears to activate musk primarily via the Rac/JNK-depen-
dent shunt pathway: (a) only interfering with JNK but not
abolishing NRG/ErbB signaling abolished Agrin-induced
musk expression, and (b) forced overexpression of MKK7,
which activates JNK but not ERK and p38 MAPKs (Davis,
Figure 7. Model for stabilization of synaptic gene expression 
through stabilization of musk expression by agrin from motor 
nerve terminal. Agrin secreted from nerve terminal activates 
preexisting MuSK to induce expression of musk via its N-box (i) 
by organizing an NRG/ErbB pathway, involving MuSK-induced 
recruitment of ErbB receptors and of muscle-derived NRG and (ii) 
by MuSK-induced activation of JNK (via Rac/Cdc42). With musk 
expression stabilized, the same pathways are used for AChR and 
erbB expression. Expression may be strengthened by NRG-1 secreted 
from nerve terminal. Complete inhibition of Agrin-induced musk 
transcription in C2C12 cells by overexpression of inactive ErbBs 
(HER2KM and HER4KM) and by dominant-negative JNK suggests 
that the two pathways are connected. The model is based on 
present data (solid arrows) and references cited (broken arrows).T
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2000), induced musk, again suggesting convergence of the
NRG/ErbB and the shunt pathways.
JNK is a plausible candidate mediating Agrin’s induction
of musk. It can phosphorylate GABP in vitro (Fromm and
Burden, 2001) and in T cells where it induces interleukin-2
(Hoffmeyer et al., 1998). Thus, Agrin-induced musk activa-
tion mediated by JNK will depend on the presence of the
N-box in the musk promoter as observed here. Consistent
with a role in Agrin-dependent gene transcription, JNK-APF
inhibited ectopic subsynaptic differentiation as assessed by
the inhibition of ectopic AChR cluster formation induced
by Agrin. A similar blockade has been found by dominant-
negative GABP DN with the same type of assay (Briguet
and Rüegg, 2000).
Our conclusion of an ErbB-independent, MuSK-induced
shunt prevailing in vivo depends on the functional expres-
sion of injected pHERKM in the muscle fibers. Evidence for
this is (a) the immunohistochemical demonstration of their
expression; (b) that pHER2KM and pHER4KM have been
functionally tested in HEK293 cells (Weiss et al., 1997); (c)
that transfection of pHER2/4KM into C2C12 cells blocks
musk and AChR  activation by Agrin, and thus, the con-
structs are functional in muscle cells; (d) that injection of
pHER4KM into muscle fibers in vivo partially inhibits the
induction of ectopic synaptic membranes by Agrin; inhibi-
tion was similar to that caused by ablation of the erbB2 gene
(Moore et al., 2001). The inhibitions by erbB2 ablation and
by pHER4KM injection were incomplete but similar in
magnitude, and they did not add. Thus, injection of
pHER4KM alone could fully block NRG/ErbB signaling in
vivo. As predicted for an NRG/ErbB-independent pathway,
the blocking effect by ErbB ablation and HER4KM overex-
pression was reduced as the level of Agrin was increased.
A direct shunt from MuSK to the nuclei is consistent with
the only marginal reduction in AChR density that we ob-
served recently at mature endplates of erbB2 /  muscle fi-
bers (Leu et al., 2003). Finally, it can explain the observation
that in neonatal rapsyn /  mice elevated levels of musk and
AChR  and   subunit genes are expressed in the synaptic
muscle region (Apel et al., 1997), although MuSK but not
ErbB receptors are aggregated (Moscoso et al., 1995).
Recently, de Kerchove D’Exaerde et al. (2002) reported
that unlike AChR  subunit mRNA, the level of endogenous
musk mRNA was not reduced in transgenic mouse muscle
expressing an inactive mutant of the transcription factor
Ets2. They concluded that musk is not or only marginally
regulated by a mechanism involving Ets transcription fac-
tors, in contrast to the findings described here. However, al-
ternative explanations are also possible (see Discussion in de
Kerchove D’Exaerde et al., 2002).
By stabilizing musk and, as a consequence, AChR and
other genes, Agrin can “stabilize” developing neuromuscular
junctions: in fetal muscle, postsynaptic-like sites begin to de-
velop in the absence of Agrin but depend on the presence of
MuSK; later in development, they become dispersed, unless
they are stabilized by Agrin from motor nerve terminals (Lin
et al., 2001; Yang et al., 2001). Apparently, NRG from
nerve terminals is not sufficient to stabilize MuSK. At ma-
ture synapses, NRG-1 secreted from the nerve is likely to
contribute more substantially to the synaptic expression of
musk because more NRG-1 will be available than can be re-
cruited by Agrin from the muscle fibers alone (Loeb et al.,
1999). Consistent with this, mice heterozygous for the rele-
vant NRG-1 isoform contain fewer AChRs than wild-type
mice in their endplates (Sandrock et al., 1997); similarly, in
wild-type mice Agrin-induced ectopic AChR clusters have
lower AChR density than endplates.
Finally, the regulation of musk by Agrin via binding of
GAPB to the N-box is similar if not identical to that pro-
posed for the localization of AChR  and   subunit gene ex-
pression to the synapse (Schaeffer et al., 1998). The promot-
ers of musk and of AChR , when activated by Agrin,
respond in a similar way to interfering with Agrin-depen-
dent signaling components, e.g., ErbBs (Meier et al.,
1998b) or JNK, and their N-boxes compete for the same
components of nuclear extracts. Thus, Agrin-activated
MuSK sets up signaling loops that are not only used to con-
trol its own expression but also that of AChR  (Fig. 7) and
potentially of other genes regulated via an N-box, such as
utrophin (Angus et al., 2001), AChR  subunit (Koike et al.,
1995; Duclert et al., 1996; Fromm and Burden, 1998;
Schaeffer et al., 1998), and AChE genes (Gramolini et al.,
1998; Chan et al., 1999). Induction of musk by agrin-acti-
vated MuSK and, via the same pathway, of major synaptic
genes downstream of MuSK is a simple way for the nerve to
orchestrate by the secretion of Agrin the formation of the
postsynaptic membrane and to stabilize it when the synapse
begins to transmit impulses.
Materials and methods
Screening of a mouse genomic library
The genomic library (packaged in Lambda FIX II Vector
®; Stratagene) was
screened with a dig-labeled 580-bp fragment corresponding to the 5  part
of the mouse nsk2/MuSK cDNA (Ganju et al., 1995). Approximately 3  
10
6 plaques were screened, and two positive clones containing upstream
and downstream regions from the first exon were further purified. 1.4 kb of
upstream and 1 kb of downstream sequence, respectively, were subcloned
into the pBluescript KS
® vector (Stratagene) and sequenced by using the
Dye-Deoxy Termination cycle sequencing method. The sequence data
available from GenBank/EMBL/DDBJ under accession no. AY114512.
5  RACE analysis
The transcription start site was determined by 5‘ RACE. RNA was extracted
from C2C12 cells using the RNeasy Mini Kit (QIAGEN). 5  RACE was per-
formed using the 5  RACE system version 2 (GIBCO BRL). The cDNA was
amplified using the anchor primer and an internal primer R1, TCTTCAAC-
CAAGGCATCTACAAG. The PCR products were cloned into pGEM-T vec-
tor
® (Promega), and 20 independent clones were sequenced.
Construction of the reporter constructs
p1.6luc-N. The 1.6-kb genomic fragment containing the region upstream of
the first exon was amplified by PCR by using the oligonucleotides 1.6F,
GAGAAGCTTTCCCTTTTCTTTGACTATAG and 1.6R, GAGAAGCTTACT-
GTTTGTGTCTGCAGCGC. This PCR product was cloned into the HindIII
site of the pGL3 vector containing the luciferase gene as a reporter
(Promega) to give p1.6luc. The same strategy was used to insert down-
stream of the luciferase gene into the BamHI site of pGL3 a 1-kb fragment
of the first intron of nsk2/musk containing the N-box by using the NboxFB,
GAGGGATTCTCCAGAGTGTTTTGCTCCTG and the NboxRB, GAGG-
GATTCTCTAGAACTCTGCATAACGC oligonucleotides, giving p1.6luc-N.
p1.6luc-Nmut. Two mutations were introduced into the N-box at  871
(Fig. 1 A) of p1.6luc-N by PCR: 871C T and 872C T. A first amplification
with, respectively, NboxFB, etsmutR, CTTAGGTGGTGTTATTTCCAATA-
CATTCCAAAGGCA and NboxFR and etsmutF, TGCCTTTGGAATGTAT-
TGGAAATAACACCACCTAAG was performed. The two products were
mixed, denatured for 5 min at 95 C, annealed 10 min at 56 C, and the an-T
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nealed product was submitted to a second PCR by using the NboxFB and
NboxFR primers. After sequencing, the mutated fragment was cloned into
the pGL3 vector as described above.
p1.6nlslacZ-Nmut. For some experiments, luciferase in p1.6luc-N was
replaced by nlslacZ, a reporter construct directing  -Gal expression to nu-
clei for easier microscopic observation. For this purpose, a KpnI-NcoI frag-
ment was excised from a 1.6luc construct and subcloned in a pLacF plas-
mid (Sanes et al., 1991). The fragment containing the N-box was added
downstream the lacZ at the SphI restriction site, using the same primers as
described above, but using SphI instead of the BamHI restriction site. The
plasmid DNA was resuspended either in Tris (5 mM) for cell transfection
and in vivo intracellular injection or in Tris 5 mM/NaCl 0.9%, pH, 7.4, for
in vivo electroporation.
Other constructs. Other constructs used have been described as indi-
cated: pnlsGFP-S6 (Hashemolhosseini et al., 2000); pHER2, pHER2KM,
pHER4, pHER4KM (Weiss et al., 1997); pGABP DN, pGABP -myc,
pGABP -myc (Briguet and Rüegg, 2000); pJNK-APF (Gupta et al., 1995),
pMKK7D (Wang et al., 1998); pLCF216  (Jones et al., 1996); pRacV12,
pRacN17 (Joneson et al., 1996).
Cell culture and transfection
C2C12 cells were cultured according to Jones et al (1999). 8   10
4 cells
were passaged onto 6-well plates that had been coated with either laminin
alone or with laminin and mini-Agrin (N257c21B8) comprising the NtA
laminin-binding site and the minimal c21AgrinB8 of chicken Agrin (Gese-
mann et al., 1996; Meier et al., 1998a). This mini-Agrin is sufficient to in-
duce AChR  subunit gene expression in vivo. Unlike full-length Agrin, it
does not carry glycosaminoglycan side chains and thus cannot bind and ac-
cumulate NRG-1 without signaling through MuSK (Jones et al., 1996; Meier
et al., 1998a,b). Myoblasts were transfected with 800 ng of reporter plas-
mid, 80 ng of pRL-TK plasmid (Promega) for normalization, and 150 ng of
the appropriate plasmid using 6  l of Fugene6 reagent (Roche Diagnostics).
Myotubes were analyzed 7 d after transfection using the dual luciferase re-
porter assay system (Promega). Light intensity was quantified with a Turner
Designs Model 20e Luminometer. NRG-1 was from R&D Systems.
Nuclear extracts and electrophoretic mobility shift assays
Muscle nuclei were collected from differentiated C2C12 myotubes accord-
ing to the protocol of Schreiber et al. (1989) with the exception that all
buffers contained a cocktail of protease inhibitors (Roche Diagnostics).
For the mobility shift assay experiments, the oligonucleotides were
as follows: etsF, TGGAATGTACCGGAAATAACACCA; etsR, TGGTGT-
TATTTCCGGTACATTCCA; etsmutF, TGGAATGTATTGGAAATAACA-
CCA; etsmutR, TGGTGTTATTTCCAATACATTCCA;  compF, AAACCTA-
GCCCGGAACTAACACCC; and  compR, GGGTGTTAGTTCCGGGCT-
AGGTTT. Annealed oligonucleotide probes were labeled with [ -
32P]ATP
using T4 polynucleotide kinase. For the binding reaction, 2 ng of labeled
probe, 2  g of poly dIdC, and 3–4  g of nuclear extract were mixed and
incubated for 20 min at RT, loaded on a 5% polyacrylamide gel and run at
200 V for 40 min. The gel was dried and exposed in a Storm imaging sys-
tem (Amersham Biosciences). Antibodies against GABP  and GABP  used
in supershift experiments have been characterized by Schaeffer et al.
(1998).
ErbB2 immunoprecipitation and Western blotting
C2C12 myotubes cultured in 10 cm plates were washed twice with ice-
cold PBS, and membrane proteins were extracted with 1 ml detergent ex-
traction buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 5
mM EGTA, 50 mM NaF, 10 mM sodium molybdate, 1 mM sodium ortho-
vanadate, 1% Triton X-100, and 1  protease inhibitor cocktail [Roche Di-
agnostics]). Extracts were cleared from cell debris by centrifugation at 4 C.
For each sample, the similar amounts of total protein was subjected to
ErbB2 immunoprecipitation with 0.1  g/ml anti-erbB2 antibody (C18;
Santa Cruz Biotechnology, Inc.) for 1 h at 4 C and incubated with protein
A–Agarose beads (Roche Diagnostics) overnight at 4 C. After washing five
times with 1 ml detergent extraction buffer, excess liquid was removed,
and the beads were boiled in 50  l SDS sample buffer. Samples were sep-
arated on a 5% acrylamide gel and transferred to Immobilon-P (Millipore)
by electroblotting. ErbB2 protein was detected by a polyclonal rabbit anti-
ErbB2 antibody (a gift from A. Badache, Friedrich Miescher Institute, Basel,
Switzerland) and with peroxidase-conjugated anti–rabbit antibody. Immu-
nocomplexes were visualized followed by ECL.
Injections of plasmids into muscle fibers in vivo
Male Wistar rats were anaesthetized with Nembutal (1 ml/kg). Single fibers
of rat soleus were injected in their proximal end plate–free region as de-
scribed (Jones et al., 1997) with 100 ng/ l of the reporter plasmid, 50 ng/ l
of the pRL-TK plasmid, the plasmids indicated, and with 50 ng/ l of the
pnlsGFP-S6 plasmid (Jones et al., 1999) for later identification of injected
fibers. After 2 wk, rats were killed with CO2, and the soleus muscles were
excised for analysis using the Dual-Luciferase
® Reporter Assay System
(Promega). Blockade of ectopic subsynaptic differentiation in vivo by JNK-
APF was tested as described by Briguet and Rüegg (2000).
Electroporation of muscles
Rats were anaesthetized, and the left soleus muscle was surgically ex-
posed. 30  l of a DNA mixture containing 55  g of the p1.6luc-N or
p1.6nlslacZ-N plasmids and 35  g of the pRL-TK plasmid were injected
into the soleus with a Hamilton syringe (gauge 34). After suturing the surgi-
cal cut, two stainless steel plate electrodes, covered with a conductive gel
allowing electrical contact with the skin, were placed at each side of the
leg. Eight pulses of 20-ms duration were delivered at 1-s intervals from a
T830 square wave electroporator (BTX) (Mir et al., 1999). Analysis of lu-
ciferase activities was as described above. Muscles electroporated with
p1.6nlslacZ-N were stained for  -Gal activity and subsequently for acetyl-
cholinesterase (Koelle and Friedenwald, 1949). Fiber bundles teased from
the muscles were examined under the microscope at 400 .
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